High Levels of mRNA Encoding IL-4 in Unstimulated Peripheral Blood Mononuclear Cells from Tuberculosis Patients Revealed by Quantitative Nested Reverse Transcriptase-Polymerase Chain Reaction; Correlations with Serum IgE Levels

References

• Gatner EM, Msibi V, Dauth J. Circulating immunoglobulin levels in patients with pulmonary tuberculosis with special reference to IgE. Tubercle 1982; 63: 113–7.
   Google Scholar
• Pherwani AV, Jayram L, Masood MA. Serum immunoglobulin E against PPD antigen in patients with pulmonary tuberculosis. J Assoc Physicians India 1993; 41: 369–70.
   Google Scholar
• Greinert U, Ernst M, Haas H, Lepp U, Schlaak M. Increased serum IgE concentration in lung tuberculosis. Pneumologie 1990; 1: 495–6 (in German).
   Google Scholar
• Yong AJ, Grange JM, Tee RD, Beck JS, Bothamley GH, Kemeny DM, et al. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. Tubercle 1989; 70: 273–9.
   PubMedGoogle Scholar
• Ray D, Saha K, Krishna KS. Serum immunoglobulin E response in sputum positive patients with pulmonary tuberculosis. Indian J Med Res 1993; 97: 151–3.
   Google Scholar
• Hussain R, Toossi Z, Hasan R, Jamil B, Dawood G, Ellner JJ. Immune response profile in patients with active tuberculosis in a BCG vaccinated area. Southeast Asian J Trop Med Public Health 1997; 28: 764–73.
   PubMedGoogle Scholar
• Adams JF, Scholvinck EH, Gie RP, Potter PC, Beyers N, Beyers AD. Decline in total serum IgE after treatment for tuberculosis. Lancet 1999; 353: 2030–3.
   PubMedGoogle Scholar
• Wilsher ML, Hagan C, Prestidge R, Wells AU, Murison G. Human in vitro immune responses to Mycobacterium tubercu losis. Tuber Lung Dis 1999; 79: 371–7.
   PubMedGoogle Scholar
• Pherwani AV, Patwari VA. Bronchial challenge with purified protein derivative of Mycobacterium tuberculosis in asthma. Indian Pediatr 1992; 29: 867–70.
   PubMedGoogle Scholar
• Alms WJ, Atamas SP, Yurovsky VV, White B. Generation of a variant of human interleukin-4 by alternative splicing. Mol Immunol 1996; 33: 361–70.
   PubMedGoogle Scholar
• Arinobu Y, Atamas SP, Otsuka T, Niiro H, Yamaoka K, Mitsuyasu H, et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-4 delta 2, on IL-4 activities in human monocytes and B cells. Cell Immunol 1999; 191: 161–7.
   PubMedGoogle Scholar
• Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J Immunol 1996; 156: 435–41.
   PubMedGoogle Scholar
• Seah GT, Rook GA. A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4 delta 2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. J Immunol Methods 1999; 228: 139–49.
   PubMedGoogle Scholar
• Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181: 385–9.
   Google Scholar
• van Crevel R, Karyadi E, Preyers F, Leenders M, Kullberg BJ, Nelwan RH, et al. Increased production of interleukin 4 by CD4 + and CD8 + T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000; 181: 1194–7.
   PubMedGoogle Scholar
• Fenhalls G, Wong A, Bezuidenhout J, van Helden P, Bardin P, Lukey PT. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect Immun 2000; 68: 2827–36.
   Google Scholar
• Rook GAW, Ristori G, Salvetti M, Giovannoni G, Thompson EJ, Stanford JL. Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. Immunol Today 2000; in press.
   Google Scholar
• Lawrence CE, Paterson JC, Higgins LM, MacDonald TT, Kennedy MW, Garside P. IL-4-regulated enteropathy in an intestinal nematode infection. Eur J Immunol 1998; 28: 267–284.
   Google Scholar
• Hernandez-Pando R, Rook GAW. The role of TNFa in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994; 82: 591–5.
   PubMed Web of Science ®Google Scholar
• Hernandez-Pando R, Pavon L, Arriaga K, Orozco H, MadridMarina V, Rook GAW. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte. Infect Immun 1997; 65: 3317–27.
   PubMed Web of Science ®Google Scholar
• Baker RW, Walker BR, Honour J, Jessop D, Shaw RJ, Lightman SL, et al. Increased cortisol : cortisone ratio in acute pulmonary tuberculosis. Am J Resp Crit Care Med 2000; 162: 1641–1647.
   PubMed Web of Science ®Google Scholar
• Turner J, Rhoades ER, Keen M, Belisle JT, Frank AA, Orme IM. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect Immun 2000; 68: 1706–9.
   PubMed Web of Science ®Google Scholar
• Rook GAW, Hernandez-Pando R. The pathogenesis of tuberculosis. Annu Rev Microbiol 1996; 50: 259–84.
   PubMed Web of Science ®Google Scholar
• Hernandez-Pando R, Pavon L, Orozco EH, Rangel J, Rook GAW. Interactions between hormone-mediated and vaccinemediated immunotherapy for pulmonary tuberculosis in Balb/ c mice. Immunology 2000; 100: 391–8.
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269–71.
   PubMed Web of Science ®Google Scholar
• Wang CC, Rook GAW. Inhibition of an established allergic response to ovalbumin in Balb/c mice by killed Mycobacterium vaccae. Immunology 1998; 93: 307–13.
   PubMed Web of Science ®Google Scholar